SEC 13F Intelligence

Managers / Q4 2018 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$80M
Q4 2018
Positions
10
Filings on Record
30
2019–present window
Filed
Feb 14, 2019
original filing

Summary

Maso Capital Partners Ltd reported $80M in U.S.-listed holdings across 10 positions for Q4 2018.

Its largest position, China Biologic Prods Hldgs I, represents 15.2% of the portfolio.

Portfolio Metrics

Largest Position
+15.2%
China Biologic Prods Hldgs I

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Other: 54.0%Common Stock: 28.7%ADR: 17.3%
  • Other · 54.0% · $43M
  • Common Stock · 28.7% · $23M
  • ADR · 17.3% · $14M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
SPDR S&P 500 ETF TRNEW+82.0K82.0K+$20M$20M
CHINA BIOLOGIC PRODS HLDGS INEW+159.2K159.2K+$12M$12M
GNWGENWORTH FINL INCNEW+2.34M2.34M+$11M$11M
YUMCYUM CHINA HLDGS INCNEW+278.0K278.0K+$9M$9M
CYOUUSDCHANGYOU COM LTDNEW+486.4K486.4K+$9M$9M
SOHUSOHU COM LTDNEW+281.3K281.3K+$5M$5M
BUNGE LIMITEDNEW+90.1K90.1K+$5M$5M
SHIRE PLCNEW+25.7K25.7K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2018

9 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CHINA BIOLOGIC PRODS HLDGS ICOM15.17%$12M159.2K
2GNWGENWORTH FINL INChistory →COM CL A13.70%$11M2.34M
3YUMCYUM CHINA HLDGS INChistory →COM11.70%$9M278.0K
4CYOUUSDCHANGYOU COM LTDhistory →ADS REP CL A11.16%$9M486.4K
5SOHUSOHU COM LTDhistory →SPONSORED ADS6.15%$5M281.3K
6BUNGE LIMITEDCOM6.05%$5M90.1K
7SHIRE PLCSPONSORED ADR5.62%$4M25.7K
8ACHCACADIA HEALTHCARE CO INChistory →COM3.30%$3M102.3K
9NAKED BRAND GROUP LIMITEDORD SHS1.40%$1M1.33M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.